Stage III Thymoma AJCC v8

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Stage III Thymoma AJCC v8 trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT03295227

Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

This phase I trial studies the sides effects and best dose of pembrolizumab in treating participants with thymoma or thymic cancer that cannot be removed by sur…

United States37 participantsStarted 2017-12-06

Treatment: Pembrolizumab

All recent trials (6 shown)

CompletedNot Applicable

NCT04662645

Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Thei…

This trial studies how well embedded palliative care works in managing symptoms in participants with stage III-IV thoracic malignancies that has come back and t…

United States68 participantsStarted 2018-12-12

Treatment: Palliative Therapy, Questionnaire Administration

CompletedNot Applicable

NCT00372840

Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer,…

RATIONALE: Printed educational materials, such as the Facing Forward Series: Life After Cancer Treatment manual, may help make the transition from cancer patien…

United States340 participantsStarted 2006-05

Treatment: educational intervention, psychosocial assessment and care

Stage III Thymoma AJCC v8

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

All recent trials (6 shown)

Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Thei…

Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer,…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

All recent trials (6 shown)

Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Thei…

Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer,…

Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma